260 related articles for article (PubMed ID: 32015438)
21. The Hippo kinase LATS2 impairs pancreatic β-cell survival in diabetes through the mTORC1-autophagy axis.
Yuan T; Annamalai K; Naik S; Lupse B; Geravandi S; Pal A; Dobrowolski A; Ghawali J; Ruhlandt M; Gorrepati KDD; Azizi Z; Lim DS; Maedler K; Ardestani A
Nat Commun; 2021 Aug; 12(1):4928. PubMed ID: 34389720
[TBL] [Abstract][Full Text] [Related]
22. AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation.
Van Nostrand JL; Hellberg K; Luo EC; Van Nostrand EL; Dayn A; Yu J; Shokhirev MN; Dayn Y; Yeo GW; Shaw RJ
Genes Dev; 2020 Oct; 34(19-20):1330-1344. PubMed ID: 32912901
[TBL] [Abstract][Full Text] [Related]
23. Osteocyte-intrinsic mTORC1 signaling restrains trabecular bone accrual in mice.
Liu Q; Liu C; Yang Y; Yang H; Chen J
J Cell Biochem; 2018 Nov; 119(11):8743-8749. PubMed ID: 30160781
[TBL] [Abstract][Full Text] [Related]
24. RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1.
Wang T; Zhang WS; Wang ZX; Wu ZW; Du BB; Li LY; Chen YF; Yang XF; Hao XY; Guo TK
Cancer Med; 2020 Feb; 9(4):1529-1543. PubMed ID: 31886628
[TBL] [Abstract][Full Text] [Related]
25. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
Shaw RJ
Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
[TBL] [Abstract][Full Text] [Related]
26. Silencing of SmgGDS, a Novel mTORC1 Inducer That Binds to RHEBs, Inhibits Malignant Mesothelioma Cell Proliferation.
Sato T; Mukai S; Ikeda H; Mishiro-Sato E; Akao K; Kobayashi T; Hino O; Shimono W; Shibagaki Y; Hattori S; Sekido Y
Mol Cancer Res; 2021 May; 19(5):921-931. PubMed ID: 33574130
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1.
Zheng M; Wang YH; Wu XN; Wu SQ; Lu BJ; Dong MQ; Zhang H; Sun P; Lin SC; Guan KL; Han J
Nat Cell Biol; 2011 Mar; 13(3):263-72. PubMed ID: 21336308
[TBL] [Abstract][Full Text] [Related]
28. Zebrafish raptor mutation inhibits the activity of mTORC1, inducing craniofacial defects due to autophagy-induced neural crest cell death.
Tucker SK; Ghosal R; Swartz ME; Zhang S; Eberhart JK
Development; 2024 Mar; 151(6):. PubMed ID: 38512806
[TBL] [Abstract][Full Text] [Related]
29. The Hippo pathway member Nf2 is required for inner cell mass specification.
Cockburn K; Biechele S; Garner J; Rossant J
Curr Biol; 2013 Jul; 23(13):1195-201. PubMed ID: 23791728
[TBL] [Abstract][Full Text] [Related]
30. TBK1 Limits mTORC1 by Promoting Phosphorylation of Raptor Ser877.
Antonia RJ; Castillo J; Herring LE; Serafin DS; Liu P; Graves LM; Baldwin AS; Hagan RS
Sci Rep; 2019 Sep; 9(1):13470. PubMed ID: 31530866
[TBL] [Abstract][Full Text] [Related]
31. Cardiac mTORC1 Dysregulation Impacts Stress Adaptation and Survival in Huntington's Disease.
Child DD; Lee JH; Pascua CJ; Chen YH; Mas Monteys A; Davidson BL
Cell Rep; 2018 Apr; 23(4):1020-1033. PubMed ID: 29694882
[TBL] [Abstract][Full Text] [Related]
32. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity.
Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP
Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Binding Kinetics of RHEB with mTORC1 by In-Cell and In Vitro Assays.
Shams R; Ito Y; Miyatake H
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445471
[TBL] [Abstract][Full Text] [Related]
34. Dynamin-dependent amino acid endocytosis activates mechanistic target of rapamycin complex 1 (mTORC1).
Shibutani S; Okazaki H; Iwata H
J Biol Chem; 2017 Nov; 292(44):18052-18061. PubMed ID: 28808055
[TBL] [Abstract][Full Text] [Related]
35. A small molecule inhibitor of Rheb selectively targets mTORC1 signaling.
Mahoney SJ; Narayan S; Molz L; Berstler LA; Kang SA; Vlasuk GP; Saiah E
Nat Commun; 2018 Feb; 9(1):548. PubMed ID: 29416044
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction.
Condon KJ; Orozco JM; Adelmann CH; Spinelli JB; van der Helm PW; Roberts JM; Kunchok T; Sabatini DM
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33483422
[TBL] [Abstract][Full Text] [Related]
37. The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168.
Xie X; Hu H; Tong X; Li L; Liu X; Chen M; Yuan H; Xie X; Li Q; Zhang Y; Ouyang H; Wei M; Huang J; Liu P; Gan W; Liu Y; Xie A; Kuai X; Chirn GW; Zhou H; Zeng R; Hu R; Qin J; Meng FL; Wei W; Ji H; Gao D
Nat Cell Biol; 2018 Mar; 20(3):320-331. PubMed ID: 29403037
[TBL] [Abstract][Full Text] [Related]
38. Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb.
Lee MN; Ha SH; Kim J; Koh A; Lee CS; Kim JH; Jeon H; Kim DH; Suh PG; Ryu SH
Mol Cell Biol; 2009 Jul; 29(14):3991-4001. PubMed ID: 19451232
[TBL] [Abstract][Full Text] [Related]
39. Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging.
Oshiro N; Rapley J; Avruch J
J Biol Chem; 2014 Jan; 289(5):2658-74. PubMed ID: 24337580
[TBL] [Abstract][Full Text] [Related]
40. PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy.
Ruf S; Heberle AM; Langelaar-Makkinje M; Gelino S; Wilkinson D; Gerbeth C; Schwarz JJ; Holzwarth B; Warscheid B; Meisinger C; van Vugt MA; Baumeister R; Hansen M; Thedieck K
Autophagy; 2017 Mar; 13(3):486-505. PubMed ID: 28102733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
